J&J's drug-eluting stents survive FDA scrutiny
The US Food and Drug Administration (FDA) has decided against restricting the use of drug-eluting cardiac stents after a two-day investigation into their potential to increase blood clots.
Archives for December 14, 2006
Dr Reddy's overcomes formulation challenge to develop 4-in-1 heart pill
Dr Reddy's Laboratories has started first clinical trials of a "four-in-one" polypill clinical trial, which could revolutionise the cardiovascular drugs market.
FDA seeks wider access to experimental drugs
Seriously ill patients in the US could soon have greater access to experimental drugs if a planned regulatory overhaul by the Food and Drug Administration (FDA) goes ahead.
Schott's pharma packaging business keeps growing
Schott has reported a 15 per cent growth rate for its pharma packaging business, three times higher than the growth of the overall pharma industry.
Ben Venue wins Vion anti-cancer contract
Vion Pharmaceuticals has awarded a manufacturing agreement with Ohio based contract manufacturers Ben Venue Laboratories to produce its lead anticancer drug, Cloretazine (VNP40101M).